Nyumbani › Multiple Myeloma › Maryland › Baltimore
Majaribio ya kliniki ya Multiple Myeloma katika Baltimore, MD
Masomo 13 ya Multiple Myeloma yanatafuta washiriki katika vituo vya Baltimore na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- Johns Hopkins Hospital, Baltimore
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 3
- University of Maryland School of Medicine, Baltimore
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
InaajiriHatua 3
- Johns Hopkins University School of Medicine JHUSOM, Baltimore
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
InaajiriHatua ya kwanza ya awali
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
InaajiriHatua 3
- Johns Hopkins Asthma & Allergy Center, Baltimore
Collection of Tissue Samples for Cancer Research
InaajiriUtafiti wa uchunguzi
- Johns Hopkins University, Baltimore
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
InaajiriHatua 3
- University of Maryland | Greenebaum Cancer Center, Baltimore
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
InaajiriHatua 3
- Research Site, Baltimore
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
InaajiriHatua 1
- University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
InaajiriHatua 3
- Greater Baltimore Medical Center, Baltimore
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
InaajiriHatua 3
- Greenebaum Cancer Center UM of MD, Baltimore
- John Hopkins, Baltimore
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
InaajiriHatua 1/2
- Sibley Memorial Hospital, Baltimore
- University of Maryland, Baltimore
- Johns Hopkins Main Center, Baltimore
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
InaajiriHatua 1/2
- Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Majaribio ya Multiple Myeloma katika miji mingine
- New York City, NYUtafiti 60
- Boston, MAUtafiti 42
- Atlanta, GAUtafiti 41
- Houston, TXUtafiti 38
- Durham, NCUtafiti 37
- Nashville, TNUtafiti 32
- Denver, COUtafiti 27
- Rochester, MNUtafiti 24
- St. Louis, MOUtafiti 24
- Columbus, OHUtafiti 24
- Baldwin Park, CAUtafiti 23
- Chicago, ILUtafiti 22
Masomo mengine katika Baltimore
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 60
- Saratani ya MatitiUtafiti 47
- Saratani ya ProstateUtafiti 43
- Saratan ya MapafuUtafiti 40
- Saratani (aina zote)Utafiti 37
- Kansari ya kolorektaliUtafiti 31
- Kansari ya PancreasUtafiti 31
- Saratani ya MetastasiUtafiti 28
- UnenepuUtafiti 25
- Kushindwa kwa MoyoUtafiti 24
- Saratani ya MkojoUtafiti 24
- KigonjwaUtafiti 22
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.